Research Paper Volume 16, Issue 7 pp 6364—6383
Metabolic score for insulin resistance predicts major adverse cardiovascular event in premature coronary artery disease
Figure 1. Flow diagram of patient selection. & Including severe cardiac value disease, decompensated heart failure, non-ischemic dilated cardiomyopathy, severe renal or hepatic disease, acute infection or inflammation, malignancy, hematologic disease or autoimmune disease.